X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs NATCO PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD NATCO PHARMA ALEMBIC LTD/
NATCO PHARMA
 
P/E (TTM) x 127.6 30.7 416.0% View Chart
P/BV x 4.7 23.2 20.4% View Chart
Dividend Yield % 0.2 0.5 48.1%  

Financials

 ALEMBIC LTD   NATCO PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
NATCO PHARMA
Mar-14
ALEMBIC LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs53877 6.0%   
Low Rs29424 6.9%   
Sales per share (Unadj.) Rs4.7223.4 2.1%  
Earnings per share (Unadj.) Rs8.831.1 28.2%  
Cash flow per share (Unadj.) Rs9.040.3 22.4%  
Dividends per share (Unadj.) Rs0.155.00 3.0%  
Dividend yield (eoy) %0.40.8 47.5%  
Book value per share (Unadj.) Rs27.7219.5 12.6%  
Shares outstanding (eoy) m267.0333.07 807.5%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x8.72.9 298.9%   
Avg P/E ratio x4.720.9 22.4%  
P/CF ratio (eoy) x4.616.1 28.2%  
Price / Book Value ratio x1.53.0 50.0%  
Dividend payout %1.716.1 10.6%   
Avg Mkt Cap Rs m10,96221,504 51.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2381,128 21.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,2607,389 17.1%  
Other income Rs m264167 157.9%   
Total revenues Rs m1,5247,556 20.2%   
Gross profit Rs m831,793 4.6%  
Depreciation Rs m61304 20.2%   
Interest Rs m0366 0.1%   
Profit before tax Rs m2851,290 22.1%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m6309 2.0%   
Profit after tax Rs m2,3431,027 228.0%  
Gross profit margin %6.624.3 27.1%  
Effective tax rate %2.123.9 8.9%   
Net profit margin %185.913.9 1,336.9%  
BALANCE SHEET DATA
Current assets Rs m1,6893,681 45.9%   
Current liabilities Rs m4863,123 15.6%   
Net working cap to sales %95.47.6 1,262.3%  
Current ratio x3.51.2 294.6%  
Inventory Days Days21789 242.4%  
Debtors Days Days8159 138.1%  
Net fixed assets Rs m1,6247,685 21.1%   
Share capital Rs m534331 161.5%   
"Free" reserves Rs m5,9606,670 89.4%   
Net worth Rs m7,4047,259 102.0%   
Long term debt Rs m104955 10.9%   
Total assets Rs m8,01011,957 67.0%  
Interest coverage x950.74.5 21,022.6%   
Debt to equity ratio x00.1 10.7%  
Sales to assets ratio x0.20.6 25.5%   
Return on assets %29.311.7 251.0%  
Return on equity %31.614.2 223.6%  
Return on capital %31.320.7 151.0%  
Exports to sales %2.939.4 7.5%   
Imports to sales %28.95.7 506.2%   
Exports (fob) Rs m372,908 1.3%   
Imports (cif) Rs m364421 86.3%   
Fx inflow Rs m373,445 1.1%   
Fx outflow Rs m365703 51.9%   
Net fx Rs m-3282,743 -12.0%   
CASH FLOW
From Operations Rs m3461,440 24.0%  
From Investments Rs m-48-1,089 4.4%  
From Financial Activity Rs m-301-353 85.3%  
Net Cashflow Rs m-3-1 201.3%  

Share Holding

Indian Promoters % 64.0 52.0 123.0%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.2 7.8 2.6%  
FIIs % 9.7 16.6 58.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 26.0 100.4%  
Shareholders   54,701 25,395 215.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   PIRAMAL ENTERPRISES  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  NOVARTIS  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jan 19, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS